Abstract:Abstract Chronic wound infections are generally of polymicrobial nature with aerobic and anaerobic bacteria, as well as fungi frequently observed in them. Wound treatment involves a series of steps including debridement of the wound, flushing and often the use of multiple wound dressings many of which are antimicrobial. Yet, many wound dressings are tested versus single species of planktonic microbes, which fails to mirror the real-life presence of biofilms. Aims Simple biofilm models are the first step to testing of any antimicrobial and wound dressing, therefore the aim of this study was to develop and validate a simple polymicrobial colony biofilm wound model comprised of Pseudomonas aeruginosa, Staphylococcus aureus and Candida albicans on RPMI-1640 agar. The model was then used to evaluate the topical disinfectant chlorohexidine and four commercially available wound dressings using the polymicrobial model. The model used was as a starting point to mimic debridement in clinical care of wounds and the effectiveness of wound dressings evaluated afterwards. Methods & results Planktonic assessment using AATCC100-2004 demonstrated that all antimicrobial wound dressings reduced the planktonic microbial burden below the limit of detection, however, when challenged with polymicrobial colony biofilms, silver wound dressings showed limited effectiveness (1–2 Log CFU reductions). In contrast a single iodine releasing wound dressing showed potent antibiofilm activity reducing all species CFUs below the limit of detection (>6 log–10 log) depending on the species. A disrupted biofilm model challenge was performed to represent the debridement of a wound and wound silver based wound dressings were found to be marginally more effective than in whole colony biofilm challenges while the iodine containing wound dressing reduced microbial recovery below the limit of detection. Conclusions In this model silver dressings were ineffective versus the whole colony biofilms but showed some recovery of activity versus the disrupted colony biofilm. The iodine wound dressing reduced the viability of all species below the level of detection. This suggests that mode of action of wound dressing should be considered for the type of biofilm challenge as should the clinical use e.g. debridement.

Predictive modelling of a novel anti-adhesion therapy to combat bacterial colonisation of burn wounds

The Development of a Pipeline for the Identification and Validation of Small-Molecule RelA Inhibitors for Use as Anti-Biofilm Drugs.

Catechol Cross-Linked Antimicrobial Peptide Hydrogels Prevent Multidrug-Resistant Acinetobacter Baumannii Infection in Burn Wounds.

Antibiotic biocompatibility assay and anti-biofilm strategies for Pseudomonas aeruginosa infection in bioengineered artificial skin substitutes

Development of a Stringent Ex Vivo-Burned Porcine Skin Wound Model to Screen Topical Antimicrobial Agents

Antibacterial Efficacy of a Chitosan-Based Hydrogel Modified With Epsilon-Poly-l-Lysine Against Pseudomonas aeruginosa in a Murine-Infected Burn Wound Model

Development of a High-Throughput ex-Vivo Burn Wound Model Using Porcine Skin, and Its Application to Evaluate New Approaches to Control Wound Infection

Synergistic efficacy of colistin and silver nanoparticles impregnated human amniotic membrane in a burn wound infected rat model

Modelling and Prediction of Bacterial Attachment to Polymers

Development, characterisation and evaluation of a simple polymicrobial colony biofilm model for testing of antimicrobial wound dressings

Microfluidic Wound Model for Studying the Behaviors of Pseudomonas Aeruginosa in Polymicrobial Biofilms

SAAP-148 Eradicates MRSA Persisters Within Mature Biofilm Models Simulating Prosthetic Joint Infection

Pharmacodynamic model of the dynamic response of Pseudomonas aeruginosa biofilms to drug treatments

Antimicrobial wound dressings for full thickness infected burn wounds

Bacterial fitness shapes the population dynamics of antibiotic-resistant and -susceptible bacteria in a model of combined antibiotic and anti-virulence treatment

Impact of mixed Staphylococcus aureus-Pseudomonas aeruginosa biofilm on susceptibility to antimicrobial treatments in a 3D in vitro model

Overcoming biological barriers to improve treatment of a Staphylococcus aureus wound infection

Studying the surface-tethered AaaA as a virulence factor and anti-P. aeruginosa drug target

Functional Materials to Overcome Bacterial Barriers and Models to Advance Their Development

Pharmacodynamic Model of the Dynamic Response of Pseudomonas aeruginosa Biofilms to Antibacterial Treatments

Simulating Anti-adhesive and Antibacterial Bifunctional Polymers for Surface Coating using BioScape